Skip to search formSkip to main contentSkip to account menu

Fumaderm

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Fumaric acid esters (FAEs) are recommended in international guidelines for induction and long‐term treatment of adults with… 
Highly Cited
2013
Highly Cited
2013
To the Editor: In the letters from Ermis et al.1 and van Oosten et al.2 published in this issue of the Journal, progressive… 
Highly Cited
2010
Highly Cited
2010
Background: Currently, there is little data available on the reliability of patch testing in patients taking immunosuppressive… 
Highly Cited
2009
Highly Cited
2009
Background: This study collected data on the safety and efficacy of fumaric acid esters (FAE; Fumaderm®) in the long‐term… 
Highly Cited
2008
Highly Cited
2008
Highly Cited
2007
Highly Cited
2007
• JDDG • 1610-0379/2007/0508-0716 Definition Systemic treatment of severe psoriasis with fumaric acid esters has been approved in… 
Review
2006
Review
2006
OBJECTIVES To evaluate the clinical effectiveness, safety, tolerability and cost-effectiveness of etanercept and efalizumab for… 
Highly Cited
1997
Highly Cited
1997
Although the effectiveness of systemic antipsoriatic treatment with fumaric acid esters has been proven, their mode of action is… 
Highly Cited
1996
Highly Cited
1996
Type 2 cytokines are thought to have a protective role in psoriasis vulgaris by dampening the activity of T helper 1 (Th1… 
Highly Cited
1995
Highly Cited
1995
Objective The aim of this study was to assess the clinical efficacy of long‐term (> 6 months) oral fumarate maintenance treatment…